The ability of several β1- and β2-blockers to exert an anti-tumor activity in NB cells has been already demonstrated [20, 21], however, the possible role played by the β3-AR in maintaining NB survival is completely unknown. This evidence concerns the gene ADRB3 and neuroblastoma.